chromogranin a
Small moleculeexperimental
Chromogranin-A (CgA) or parathyroid secretory protein 1 is encoded in the human by the gene CHGA. Cga is a member of the granin family of neuroendocrine secretory proteins. As such, it is located in secretory vesicles of neurons and endocrine cells such as islet beta cell secretory granules in the pancreas. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jun 1, 2012 (NCT02759718)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Chromogranin-ASupplementation
CHGA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaChromogranin-A ↗
- WikipediaChromogranin A ↗
Also known as
- cga
- chromogranin a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02759718 | Phase 4 | Jun 1, 2012 | Novartis, University of Ulsan |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 1 | 0 | 1 | 2012 |
| University of Ulsan | Academic/Hospital | 1 | 1 | 1 | 2012 |
2 organizations
Page 1 / 1